Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Development of a Fuel-Based Oil and Gas Inventory of Nitrogen Oxides Emissions.

Gorchov Negron AM, McDonald BC, McKeen SA, Peischl J, Ahmadov R, de Gouw JA, Frost GJ, Hastings MG, Pollack IB, Ryerson TB, Thompson C, Warneke C, Trainer M.

Environ Sci Technol. 2018 Sep 4;52(17):10175-10185. doi: 10.1021/acs.est.8b02245. Epub 2018 Aug 17.

PMID:
30071716
2.

Editorial: Cognitive and Neuroimaging Effects of Chemotherapy: Evidence Across Cancer Types and Treatment Regimens.

McDonald BC.

J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx096. No abstract available.

PMID:
30053073
3.

Southeast Atmosphere Studies: learning from model-observation syntheses.

Mao J, Carlton A, Cohen RC, Brune WH, Brown SS, Wolfe GM, Jimenez JL, Pye HOT, Ng NL, Xu L, McNeill VF, Tsigaridis K, McDonald BC, Warneke C, Guenther A, Alvarado MJ, de Gouw J, Mickley LJ, Leibensperger EM, Mathur R, Nolte CG, Portmann RW, Unger N, Tosca M, Horowitz LW.

Atmos Chem Phys. 2018;18(4):2615-2651. doi: 10.5194/acp-18-2615-2018. Epub 2018 Feb 22.

4.

Modeling Ozone in the Eastern U.S. using a Fuel-Based Mobile Source Emissions Inventory.

McDonald BC, McKeen SA, Cui YY, Ahmadov R, Kim SW, Frost GJ, Pollack IB, Peischl J, Ryerson TB, Holloway JS, Graus M, Warneke C, Gilman JB, de Gouw JA, Kaiser J, Keutsch FN, Hanisco TF, Wolfe GM, Trainer M.

Environ Sci Technol. 2018 Jul 3;52(13):7360-7370. doi: 10.1021/acs.est.8b00778. Epub 2018 Jun 22.

PMID:
29870662
5.

Unexpected slowdown of US pollutant emission reduction in the past decade.

Jiang Z, McDonald BC, Worden H, Worden JR, Miyazaki K, Qu Z, Henze DK, Jones DBA, Arellano AF, Fischer EV, Zhu L, Boersma KF.

Proc Natl Acad Sci U S A. 2018 May 15;115(20):5099-5104. doi: 10.1073/pnas.1801191115. Epub 2018 Apr 30.

6.

Diurnal Variability and Emission Pattern of Decamethylcyclopentasiloxane (D5) from the Application of Personal Care Products in Two North American Cities.

Coggon MM, McDonald BC, Vlasenko A, Veres PR, Bernard F, Koss AR, Yuan B, Gilman JB, Peischl J, Aikin KC, DuRant J, Warneke C, Li SM, de Gouw JA.

Environ Sci Technol. 2018 May 15;52(10):5610-5618. doi: 10.1021/acs.est.8b00506. Epub 2018 Apr 25.

PMID:
29659257
7.

The Impact of Using Different Reference Populations on Measurement of Breast Cancer-Related Cognitive Impairment Rates.

Clapp JD, Luta G, Small BJ, Ahles TA, Root JC, Graham D, Hurria A, Jacobsen PB, Jim H, McDonald BC, Stern RA, Saykin AJ, Mandelblatt JS; Thinking and Living with Cancer (TLC) Study.

Arch Clin Neuropsychol. 2018 Feb 17. doi: 10.1093/arclin/acx142. [Epub ahead of print]

PMID:
29471454
8.

Volatile chemical products emerging as largest petrochemical source of urban organic emissions.

McDonald BC, de Gouw JA, Gilman JB, Jathar SH, Akherati A, Cappa CD, Jimenez JL, Lee-Taylor J, Hayes PL, McKeen SA, Cui YY, Kim SW, Gentner DR, Isaacman-VanWertz G, Goldstein AH, Harley RA, Frost GJ, Roberts JM, Ryerson TB, Trainer M.

Science. 2018 Feb 16;359(6377):760-764. doi: 10.1126/science.aaq0524.

PMID:
29449485
9.

Neurodevelopment in Young Children Born to HIV-Infected Mothers: A Meta-analysis.

McHenry MS, McAteer CI, Oyungu E, McDonald BC, Bosma CB, Mpofu PB, Deathe AR, Vreeman RC.

Pediatrics. 2018 Feb;141(2). pii: e20172888. doi: 10.1542/peds.2017-2888. Review.

PMID:
29374109
10.

International Cognition and Cancer Task Force Recommendations for Neuroimaging Methods in the Study of Cognitive Impairment in Non-CNS Cancer Patients.

Deprez S, Kesler SR, Saykin AJ, Silverman DHS, de Ruiter MB, McDonald BC.

J Natl Cancer Inst. 2018 Mar 1;110(3):223-231. doi: 10.1093/jnci/djx285.

PMID:
29365201
11.

Cognitive complaints in older adults at risk for Alzheimer's disease are associated with altered resting-state networks.

Contreras JA, Goñi J, Risacher SL, Amico E, Yoder K, Dzemidzic M, West JD, McDonald BC, Farlow MR, Sporns O, Saykin AJ.

Alzheimers Dement (Amst). 2016 Dec 22;6:40-49. doi: 10.1016/j.dadm.2016.12.004. eCollection 2017.

12.

Methylphenidate and Memory and Attention Adaptation Training for Persistent Cognitive Symptoms after Traumatic Brain Injury: A Randomized, Placebo-Controlled Trial.

McDonald BC, Flashman LA, Arciniegas DB, Ferguson RJ, Xing L, Harezlak J, Sprehn GC, Hammond FM, Maerlender AC, Kruck CL, Gillock KL, Frey K, Wall RN, Saykin AJ, McAllister TW.

Neuropsychopharmacology. 2017 Aug;42(9):1766-1775. doi: 10.1038/npp.2016.261. Epub 2016 Nov 22.

13.

Altered Brain Connectivity in Early Postmenopausal Women with Subjective Cognitive Impairment.

Vega JN, Zurkovsky L, Albert K, Melo A, Boyd B, Dumas J, Woodward N, McDonald BC, Saykin AJ, Park JH, Naylor M, Newhouse PA.

Front Neurosci. 2016 Sep 23;10:433. eCollection 2016.

14.

Neuroepidemiology of cancer and treatment-related neurocognitive dysfunction in adult-onset cancer patients and survivors.

Jean-Pierre P, McDonald BC.

Handb Clin Neurol. 2016;138:297-309. doi: 10.1016/B978-0-12-802973-2.00017-3. Review.

PMID:
27637965
15.

Alpha-synuclein (SNCA) polymorphisms exert protective effects on memory after mild traumatic brain injury.

Shee K, Lucas A, Flashman LA, Nho K, Tsongalis GJ, McDonald BC, Saykin AJ, McAllister TW, Rhodes CH.

Neurosci Lett. 2016 Sep 6;630:241-246. doi: 10.1016/j.neulet.2016.07.057. Epub 2016 Jul 29.

16.

Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment.

Zanville NR, Nudelman KN, Smith DJ, Von Ah D, McDonald BC, Champion VL, Saykin AJ.

Support Care Cancer. 2016 Nov;24(11):4779-89. doi: 10.1007/s00520-016-3329-5. Epub 2016 Jul 28.

17.

Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.

Risacher SL, McDonald BC, Tallman EF, West JD, Farlow MR, Unverzagt FW, Gao S, Boustani M, Crane PK, Petersen RC, Jack CR Jr, Jagust WJ, Aisen PS, Weiner MW, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative.

JAMA Neurol. 2016 Jun 1;73(6):721-32. doi: 10.1001/jamaneurol.2016.0580.

18.

The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests.

Rattanabannakit C, Risacher SL, Gao S, Lane KA, Brown SA, McDonald BC, Unverzagt FW, Apostolova LG, Saykin AJ, Farlow MR.

J Alzheimers Dis. 2016;51(4):1145-55. doi: 10.3233/JAD-150729.

19.

Increased brain activation during working memory processing after pediatric mild traumatic brain injury (mTBI).

Westfall DR, West JD, Bailey JN, Arnold TW, Kersey PA, Saykin AJ, McDonald BC.

J Pediatr Rehabil Med. 2015;8(4):297-308. doi: 10.3233/PRM-150348.

20.

Imaging Brain Networks After Cancer and Chemotherapy: Advances Toward Etiology and Unanswered Questions.

Nudelman KN, McDonald BC, Saykin AJ.

JAMA Oncol. 2016 Feb;2(2):174-6. doi: 10.1001/jamaoncol.2015.4551. No abstract available.

21.

Cerebral Perfusion and Gray Matter Changes Associated With Chemotherapy-Induced Peripheral Neuropathy.

Nudelman KN, McDonald BC, Wang Y, Smith DJ, West JD, O'Neill DP, Zanville NR, Champion VL, Schneider BP, Saykin AJ.

J Clin Oncol. 2016 Mar 1;34(7):677-83. doi: 10.1200/JCO.2015.62.1276. Epub 2015 Nov 2.

22.

GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP.

Ramanan VK, Risacher SL, Nho K, Kim S, Shen L, McDonald BC, Yoder KK, Hutchins GD, West JD, Tallman EF, Gao S, Foroud TM, Farlow MR, De Jager PL, Bennett DA, Aisen PS, Petersen RC, Jack CR Jr, Toga AW, Green RC, Jagust WJ, Weiner MW, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Brain. 2015 Oct;138(Pt 10):3076-88. doi: 10.1093/brain/awv231. Epub 2015 Aug 11.

23.

Neurobiological mechanisms associated with facial affect recognition deficits after traumatic brain injury.

Neumann D, McDonald BC, West J, Keiski MA, Wang Y.

Brain Imaging Behav. 2016 Jun;10(2):569-80. doi: 10.1007/s11682-015-9415-3.

24.

High-resolution mapping of sources contributing to urban air pollution using adjoint sensitivity analysis: benzene and diesel black carbon.

Bastien LA, McDonald BC, Brown NJ, Harley RA.

Environ Sci Technol. 2015 Jun 16;49(12):7276-84. doi: 10.1021/acs.est.5b00686. Epub 2015 May 22.

PMID:
26001097
25.

Reliable change in neuropsychological assessment of breast cancer survivors.

Andreotti C, Root JC, Schagen SB, McDonald BC, Saykin AJ, Atkinson TM, Li Y, Ahles TA.

Psychooncology. 2016 Jan;25(1):43-50. doi: 10.1002/pon.3799. Epub 2015 Mar 23.

26.

Long-term trends in California mobile source emissions and ambient concentrations of black carbon and organic aerosol.

McDonald BC, Goldstein AH, Harley RA.

Environ Sci Technol. 2015 Apr 21;49(8):5178-88. doi: 10.1021/es505912b. Epub 2015 Mar 31.

PMID:
25793355
27.

Functional neuroanatomical correlates of episodic memory impairment in early phase psychosis.

Francis MM, Hummer TA, Vohs JL, Yung MG, Liffick E, Mehdiyoun NF, Radnovich AJ, McDonald BC, Saykin AJ, Breier A.

Brain Imaging Behav. 2016 Mar;10(1):1-11. doi: 10.1007/s11682-015-9357-9.

28.

Comprehensive gene- and pathway-based analysis of depressive symptoms in older adults.

Nho K, Ramanan VK, Horgusluoglu E, Kim S, Inlow MH, Risacher SL, McDonald BC, Farlow MR, Foroud TM, Gao S, Callahan CM, Hendrie HC, Niculescu AB, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

J Alzheimers Dis. 2015;45(4):1197-206. doi: 10.3233/JAD-148009.

29.

Decreased cerebral blood flow in chronic pediatric mild TBI: an MRI perfusion study.

Wang Y, West JD, Bailey JN, Westfall DR, Xiao H, Arnold TW, Kersey PA, Saykin AJ, McDonald BC.

Dev Neuropsychol. 2015 Jan;40(1):40-4. doi: 10.1080/87565641.2014.979927.

30.

Protective variant for hippocampal atrophy identified by whole exome sequencing.

Nho K, Kim S, Risacher SL, Shen L, Corneveaux JJ, Swaminathan S, Lin H, Ramanan VK, Liu Y, Foroud TM, Inlow MH, Siniard AL, Reiman RA, Aisen PS, Petersen RC, Green RC, Jack CR Jr, Weiner MW, Baldwin CT, Lunetta KL, Farrer LA; MIRAGE (Multi-Institutional Research on Alzheimer Genetic Epidemiology) Study, Furney SJ, Lovestone S, Simmons A, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H; AddNeuroMed Consortium, McDonald BC, Farlow MR, Ghetti B; Indiana Memory and Aging Study, Huentelman MJ, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative.

Ann Neurol. 2015 Mar;77(3):547-52. doi: 10.1002/ana.24349. Epub 2015 Feb 14.

31.

Association of cancer history with Alzheimer's disease onset and structural brain changes.

Nudelman KN, Risacher SL, West JD, McDonald BC, Gao S, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative.

Front Physiol. 2014 Oct 31;5:423. doi: 10.3389/fphys.2014.00423. eCollection 2014.

32.

FASTKD2 is associated with memory and hippocampal structure in older adults.

Ramanan VK, Nho K, Shen L, Risacher SL, Kim S, McDonald BC, Farlow MR, Foroud TM, Gao S, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Aisen PS, Petersen RC, Jack CR Jr, Shaw LM, Trojanowski JQ, Weiner MW, Green RC, Toga AW, De Jager PL, Yu L, Bennett DA, Saykin AJ.

Mol Psychiatry. 2015 Oct;20(10):1197-204. doi: 10.1038/mp.2014.142. Epub 2014 Nov 11.

33.

Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusion.

Nudelman KN, Wang Y, McDonald BC, Conroy SK, Smith DJ, West JD, O'Neill DP, Schneider BP, Saykin AJ.

PLoS One. 2014 May 9;9(5):e96713. doi: 10.1371/journal.pone.0096713. eCollection 2014.

34.

Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking.

Ahles TA, Li Y, McDonald BC, Schwartz GN, Kaufman PA, Tsongalis GJ, Moore JH, Saykin AJ.

Psychooncology. 2014 Dec;23(12):1382-90. doi: 10.1002/pon.3545. Epub 2014 Apr 30.

35.

Neuroimaging and facial affect processing: implications for traumatic brain injury.

Neumann D, Keiski MA, McDonald BC, Wang Y.

Brain Imaging Behav. 2014 Sep;8(3):460-73. doi: 10.1007/s11682-013-9285-5. Review.

PMID:
24363220
36.

Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?

Mandelblatt JS, Hurria A, McDonald BC, Saykin AJ, Stern RA, VanMeter JW, McGuckin M, Traina T, Denduluri N, Turner S, Howard D, Jacobsen PB, Ahles T; Thinking and Living With Cancer Study.

Semin Oncol. 2013 Dec;40(6):709-25. doi: 10.1053/j.seminoncol.2013.09.006. Review.

37.

Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research.

Saykin AJ, de Ruiter MB, McDonald BC, Deprez S, Silverman DH.

Brain Imaging Behav. 2013 Dec;7(4):363-73. doi: 10.1007/s11682-013-9283-7.

38.

Neuroimaging, cancer, and cognition: state of the knowledge.

Holohan KN, Von Ah D, McDonald BC, Saykin AJ.

Semin Oncol Nurs. 2013 Nov;29(4):280-7. doi: 10.1016/j.soncn.2013.08.008. Review.

39.

Cholinergic Enhancement of Brain Activation in Mild Cognitive Impairment during Episodic Memory Encoding.

Risacher SL, Wang Y, Wishart HA, Rabin LA, Flashman LA, McDonald BC, West JD, Santulli RB, Saykin AJ.

Front Psychiatry. 2013 Sep 17;4:105. doi: 10.3389/fpsyt.2013.00105. eCollection 2013.

40.

Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations.

McDonald BC, Saykin AJ.

Brain Imaging Behav. 2013 Dec;7(4):374-87. doi: 10.1007/s11682-013-9256-x. Review.

41.

Long-term trends in motor vehicle emissions in u.s. urban areas.

McDonald BC, Gentner DR, Goldstein AH, Harley RA.

Environ Sci Technol. 2013 Sep 3;47(17):10022-31. doi: 10.1021/es401034z. Epub 2013 Aug 19.

PMID:
23915291
42.

Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel.

Kim S, Swaminathan S, Inlow M, Risacher SL, Nho K, Shen L, Foroud TM, Petersen RC, Aisen PS, Soares H, Toledo JB, Shaw LM, Trojanowski JQ, Weiner MW, McDonald BC, Farlow MR, Ghetti B, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

PLoS One. 2013 Jul 23;8(7):e70269. doi: 10.1371/journal.pone.0070269. Print 2013.

43.

Integrating imaging findings in evaluating the post-chemotherapy brain.

Pomykala KL, de Ruiter MB, Deprez S, McDonald BC, Silverman DH.

Brain Imaging Behav. 2013 Dec;7(4):436-52. doi: 10.1007/s11682-013-9239-y. Review.

PMID:
23828813
44.

Chemotherapy-induced amenorrhea: a prospective study of brain activation changes and neurocognitive correlates.

Conroy SK, McDonald BC, Ahles TA, West JD, Saykin AJ.

Brain Imaging Behav. 2013 Dec;7(4):491-500. doi: 10.1007/s11682-013-9240-5.

45.

Identification of functional variants from whole-exome sequencing, combined with neuroimaging genetics.

Nho K, Corneveaux JJ, Kim S, Lin H, Risacher SL, Shen L, Swaminathan S, Ramanan VK, Liu Y, Foroud T, Inlow MH, Siniard AL, Reiman RA, Aisen PS, Petersen RC, Green RC, Jack CR, Weiner MW, Baldwin CT, Lunetta K, Farrer LA; Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study, Furney SJ, Lovestone S, Simmons A, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H; AddNeuroMed Consortium, McDonald BC, Farlow MR, Ghetti B; Indiana Memory and Aging Study, Huentelman MJ, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Mol Psychiatry. 2013 Jul;18(7):739. doi: 10.1038/mp.2013.81. No abstract available.

46.

Long-term seizure, cognitive, and psychiatric outcome following trans-middle temporal gyrus amygdalohippocampectomy and standard temporal lobectomy.

Bujarski KA, Hirashima F, Roberts DW, Jobst BC, Gilbert KL, Roth RM, Flashman LA, McDonald BC, Saykin AJ, Scott RC, Dinnerstein E, Preston J, Williamson PD, Thadani VM.

J Neurosurg. 2013 Jul;119(1):16-23. doi: 10.3171/2013.3.JNS12714. Epub 2013 Apr 26.

47.

Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment.

Nho K, Corneveaux JJ, Kim S, Lin H, Risacher SL, Shen L, Swaminathan S, Ramanan VK, Liu Y, Foroud T, Inlow MH, Siniard AL, Reiman RA, Aisen PS, Petersen RC, Green RC, Jack CR, Weiner MW, Baldwin CT, Lunetta K, Farrer LA; Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study, Furney SJ, Lovestone S, Simmons A, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H; AddNeuroMed Consortium, McDonald BC, Farlow MR, Ghetti B; Indiana Memory and Aging Study, Huentelman MJ, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Mol Psychiatry. 2013 Jul;18(7):781-7. doi: 10.1038/mp.2013.24. Epub 2013 Apr 23.

48.

Altered default mode network connectivity in older adults with cognitive complaints and amnestic mild cognitive impairment.

Wang Y, Risacher SL, West JD, McDonald BC, Magee TR, Farlow MR, Gao S, O'Neill DP, Saykin AJ.

J Alzheimers Dis. 2013;35(4):751-60. doi: 10.3233/JAD-130080.

49.

PARP1 gene variation and microglial activity on [11C]PBR28 PET in older adults at risk for Alzheimer's disease.

Kim S, Nho K, Risacher SL, Inlow M, Swaminathan S, Yoder KK, Shen L, West JD, McDonald BC, Tallman EF, Hutchins GD, Fletcher JW, Farlow MR, Ghetti B, Saykin AJ.

Multimodal Brain Image Anal (2013). 2013;8159:150-158.

50.

Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage.

Conroy SK, McDonald BC, Smith DJ, Moser LR, West JD, Kamendulis LM, Klaunig JE, Champion VL, Unverzagt FW, Saykin AJ.

Breast Cancer Res Treat. 2013 Jan;137(2):493-502. doi: 10.1007/s10549-012-2385-x. Epub 2012 Dec 22.

Supplemental Content

Loading ...
Support Center